Abstract-Venous thromboembolism (VTE) occurs for the first time in Ϸ100 persons per 100,000 each year in the United States, and rises exponentially from Ͻ5 cases per 100,000 persons Ͻ15 years old to Ϸ500 cases (0.5%) per 100,000 persons at age 80 years. Approximately one third of patients with symptomatic VTE manifest pulmonary embolism (PE), whereas two thirds manifest deep vein thrombosis (DVT) alone. Despite anticoagulant therapy, VTE recurs frequently in the first few months after the initial event, with a recurrence rate of Ϸ7% at 6 months. Death occurs in Ϸ6% of DVT cases and 12% of PE cases within 1 month of diagnosis. The time of year may affect the occurrence of VTE, with a higher incidence in the winter than in the summer. One major risk factor for VTE is ethnicity, with a significantly higher incidence among Caucasians and African Americans than among Hispanic persons and AsianPacific Islanders. Overall, Ϸ25% to 50% of patient with first-time VTE have an idiopathic condition, without a readily identifiable risk factor. Early mortality after VTE is strongly associated with presentation as PE, advanced age, cancer, and underlying cardiovascular disease.
Incidence of VTEA number of studies have focused specifically on the epidemiology of VTE. Anderson et al determined the incidence of VTE in Worcester, Massachusetts, over an 18-month period in the mid 1980s by reviewing the hospital discharge records of all patients coded as having VTE, including both recurrent and first-time episodes. The number of cases (nϭ405) was small, and 97% were Caucasian.